tVNS calms overactive nerves and is approved for epilepsy, chronic migraine, depression, and Prader–Willi syndrome. Studies additionally show—often a reduction of ≥50% in epileptic seizures—as well as improvements in depression, anxiety, and chronic pain. Further potential applications include, among others, Crohn’s disease, stroke rehabilitation, tinnitus, sleep disorders, and irritable bowel syndrome.


